Download Files:
Tafamidis meglumine
SKU
HY-14852A-10 mg
Category Reference compound
Tags Neurological Disease, Neuronal Signaling, Transthyretin (TTR)
$60 – $450
Products Details
Product Description
– Tafamidis meglumine (Fx-1006A) is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis meglumine inhibits amyloidogenesis[1].
Web ID
– HY-14852A
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C21H24Cl2N2O8
References
– [1]Bulawa CE, et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9629-34.
CAS Number
– 951395-08-7
Molecular Weight
– 503.33
Compound Purity
– 99.52
SMILES
– O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O.O[C@@H]([C@@H]([C@@H](CO)O)O)[C@@H](O)CNC
Clinical Information
– Launched
Research Area
– Neurological Disease
Solubility
– DMSO : 12.5 mg/mL (ultrasonic)|H2O : ≥ mg/mL
Target
– Transthyretin (TTR)
Pathway
– Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.